Chunde Li

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5):395-405
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Antonarakis ES; Piulats JM; Gross-Goupil M; Goh J; Ojamaa K; Hoimes CJ; Vaishampayan U; Berger R; Sezer A; Alanko T; de Wit R; Li C; Omlin A; Procopio G; Fukasawa S; Tabata K-I; Park SH; Feyerabend S; Drake CG; Wu H; Qiu P; Kim J; Poehlein C; de Bono JS
Article: SPRINGERPLUS. 2016;5(1):1861
Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells
Ma Y; Miao Y; Peng Z; Sandgren J; De Stahl TD; Huss M; Lennartsson L; Liu Y; Nister M; Nilsson S; Li C
Article: PLOS ONE. 2016;11(1):e0145545
Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material
Peng Z; Andersson K; Lindholm J; Dethlefsen O; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2014;17(1):81-90
An expression signature at diagnosis to estimate prostate cancer patients' overall survival
Peng Z; Skoog L; Hellborg H; Jonstam G; Wingmo I-L; Hjalm-Eriksson M; Harmenberg U; Cedermark GC; Andersson K; Ahrlund-Richter L; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: PLOS ONE. 2014;9(10):e109610
Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells
Peng Z; Andersson K; Lindholm J; Bodin I; Pramana S; Pawitan Y; Nister M; Nilsson S; Li C
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2010;29(1):162
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
Xing Z; Zhou Z; Yu R; Li S; Li C; Nilsson S; Liu Z
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2008;16(12):1521-1525
Influence of MUC1 genetic variation on prostate cancer risk and survival
Strawbridge RJ; Nister M; Brismar K; Li C; Lindstrom S
Article: GROWTH HORMONE & IGF RESEARCH. 2007;17(5):392-398
GHR exon 3 polymorphism:: Association with type 2 diabetes mellitus and metabolic disorder
Strawbridge RJ; Karvestedt L; Li C; Efendic S; Ostenson CG; Gu HF; Brismar K
Article: CANCER RESEARCH. 2007;67(18):8504-8510
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
Article: MODERN PATHOLOGY. 2007;20(4):467-473
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Lapointe J; Kim YH; Miller MA; Li C; Kaygusuz G; van de Rijn M; Huntsman DG; Brooks JD; Pollack JR
Article: CANCER RESEARCH. 2005;65(18):8118-8124
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer
Kim H; Lapointe J; Kaygusuz G; Ong DE; Li CD; van de Rijn M; Brooks JD; Pollack JR
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(5):1003-1007
Mutation analysis of the BRG1 gene in prostate cancer clinical samples
Valdman A; Nordenskjöld A; Fang XL; Naito A; Al-Shukri S; Larsson C; Ekman P; Li CD
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2003;11(4):529-533
Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene
Li CD; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Article: ONCOGENE. 2000;19(11):1392-1399
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
Alimov A; Kost-Alimova M; Liu J; Li CD; Bergerheim U; Imreh S; Klein G; Zabarovsky ER
Article: EUROPEAN UROLOGY. 2000;37(3):358-365
Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer
Marano A; Pan Y; Li CD; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Article: ANTICANCER RESEARCH. 1999;19(5B):3841-3846
Somatic mutation and homozygous deletion of PTEN/MMAC1 gene at 10q23 in renal cell carcinoma
Alimov A; Li CD; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Article: PROSTATE. 1999;39(4):262-268
Links between genetic and environmental factors and prostate cancer risk
Ekman P; Grönberg H; Matsuyama H; Kivineva M; Bergerheim USR; Li CD
Article: GENES CHROMOSOMES & CANCER. 1999;24(3):175-182
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer
Li CD; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim USR
Article: PROSTATE. 1998;36(1):31-38
Chromosome 16q24 deletion and decreased E-cadherin expression:: Possible association with metastatic potential in prostate cancer
Pan Y; Matsuyama H; Wang NN; Yoshihiro S; Häggarth L; Li C; Tribukait B; Ekman P; Bergerheim USR
Article: ONCOGENE. 1998;16(4):481-487
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
Li CD; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim USR
Article: HUMAN MUTATION. 1998;Suppl 1:s31-s33
Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by southern blot and direct genomic DNA sequencing
Li CD; Weber G; Ekman P; Lagercrantz J; Norlen BJ; Akerstrom G; Nordenskjold M; Bergerheim USR
Article: CANCER GENETICS. 1996;86(2):95-101
Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines
Bergerheim USR; Soderhall M; Zabarovsky E; Franzen B; ManneborgSandlund A; Li CD; Jacobson SH; Auer G; Klein G; Collins VP
Article: CYTOGENETIC AND GENOME RESEARCH. 1996;75(1):17-21
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization
Bentz M; Bergerheim USR; Li C; Joos S; Werner CA; Baudis M; Gnarra J; Merino MJ; Zbar B; Linehan WM; Lichter P
Visa fler

Alla övriga publikationer

Corrigendum: SPRINGERPLUS. 2016;5(1):2084
Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.
Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Thesis / dissertation: 1999
Tracking functional changes in the cancer genome : a molecular genetic analysis of renal and prostatic carcinomas using PCR based techniques by a candidate chromosome and candidate gene approach
Li, Chunde
Published conference paper: BRITISH JOURNAL OF UROLOGY. 1997;79:35-41
Environmental and genetic factors: A possible link with prostate cancer
Ekman P; Pan Y; Li C; Dich J

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027

Examina och utbildning

Docent, experimentell onkologi, Karolinska Institutet, 2015
MEDICINE DOKTORSEXAMEN, INST F KIRURGISK VETENSKAP (K3), Karolinska Institutet, 1999

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI